Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women
NCT ID: NCT04463940
Last Updated: 2022-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2020-06-30
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Oxidative Stress Contents in Jordanian Pregnant Women With Preeclampsia
NCT07119034
Detection and Identification of Preeclampsia Via Volatile Biomarkers
NCT01291342
Study of Association Between Maternal Uric Acid , Maternal and Fetal Outcome in Pregnant Women With Hypertension
NCT01523327
Pre-Eclampsia Prediction By Doppler Screening Of Uterine Arteries And Angiogenic Factors In Second Trimester Of Pregnancy
NCT00725660
Kidney Injury Biomarkers in Preeclampsia
NCT03217916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Umbilical cord arterial blood
participant's umbilical cord arterial blood will be obtained
No intervention
No intervention
Umbilical cord venus blood
participant's umbilical cord Venus blood will be obtained
No intervention
No intervention
Maternal blood
participant's blood will be obtained
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barzilai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simon Shanhav
Dr Simon Shenhav, head of High Risk Pregnancy Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simon Shenhav, Dr
Role: PRINCIPAL_INVESTIGATOR
Barzilai University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barzilai Medical Center
Ashkelon, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Simon Shenhav
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0024-19-BRZ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.